Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  147 results for ""Idiopathic Pulmonary Fibrosis""

Your Filters

Publisher : sage publications
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Exploring therapeutic targets for molecular therapy of idiopathic pulmonary fibrosis.

  • Authors : Li Y; National Regional Children's Medical Center (Northwest), Key Laboratory of Precision Medicine to Pediatric Diseases of Shaanxi Province, Xi'an Key Laboratory of Children's Health and Diseases, Shaanxi Institute for Pediatric Diseases, Xi'an Children's Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.; First Department of Respiratory Diseases, Xi'an Children's Hospital, Affiliated Children's Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, People's Republic of China.

Subjects: Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/drug therapy ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/metabolism ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/pathology

  • Source: Science progress [Sci Prog] 2024 Apr-Jun; Vol. 107 (2), pp. 368504241247402.Publisher: SAGE Publications Country of Publication: England NLM ID: 0411361 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

The Impact of Integrated Palliative Care on Survival in Idiopathic Pulmonary Fibrosis: A Retrospective Multicenter Comparison.

  • Authors : Lu-Song J; Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.; Bakal JA

Subjects: Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/therapy ; Hospice and Palliative Care Nursing*; Humans

  • Source: The American journal of hospice & palliative care [Am J Hosp Palliat Care] 2024 Jun; Vol. 41 (6), pp. 610-618. Date of Electronic Publication: 2023 Aug 08.Publisher: Sage Publications Country of Publication: United States NLM ID: 9008229 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Understanding the lived experience of idiopathic pulmonary fibrosis and how this shapes views on home-based pulmonary rehabilitation in Delhi, India.

  • Authors : Hanif H; Metro Centre for Respiratory Disease, Metro Hospital and Heart Institute, Noida, India.; Ahmed O

Subjects: Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/rehabilitation ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/psychology ; Caregivers*/Caregivers*/Caregivers*/psychology

  • Source: Chronic respiratory disease [Chron Respir Dis] 2024 Jan-Dec; Vol. 21, pp. 14799731241258216.Publisher: SAGE Publications Country of Publication: England NLM ID: 101197408 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Validation of a Novel Clinical Dyspnea Scale - A Retrospective Pilot Study.

  • Authors : Kalluri M; Department of Medicine, Pulmonary Division, University of Alberta, and Alberta Health Services, Edmonton, AB, Canada.; Cui Y

Subjects: Activities of Daily Living* ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/complications ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/diagnosis

  • Source: The American journal of hospice & palliative care [Am J Hosp Palliat Care] 2024 Mar; Vol. 41 (3), pp. 253-261. Date of Electronic Publication: 2023 Mar 28.Publisher: Sage Publications Country of Publication: United States NLM ID: 9008229 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Clinical implications of frailty assessed in hospitalized patients with acute-exacerbation of interstitial lung disease.

  • Authors : Van Hollebeke M; Department of Physical Therapy, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.

Subjects: Frailty*/Frailty*/Frailty*/complications ; Frailty*/Frailty*/Frailty*/epidemiology ; Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/diagnosis

  • Source: Chronic respiratory disease [Chron Respir Dis] 2024 Jan-Dec; Vol. 21, pp. 14799731241240786.Publisher: SAGE Publications Country of Publication: England NLM ID: 101197408 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Impact of antifibrotic therapy on disease progression, all-cause mortality, and risk of acute exacerbation in non-IPF fibrosing interstitial lung diseases: evidence from a meta-analysis of randomized controlled trials and prospective controlled studies.

  • Authors : Li DY; Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.; Liu X

Subjects: Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/Lung Diseases, Interstitial*/drug therapy ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/diagnosis ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/drug therapy

  • Source: Therapeutic advances in respiratory disease [Ther Adv Respir Dis] 2024 Jan-Dec; Vol. 18, pp. 17534666241232561.Publisher: SAGE Publications Country of Publication: England NLM ID: 101316317 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Venous thromboembolism in patients with idiopathic pulmonary fibrosis, based on nationwide claim data.

  • Authors : Lee JH; Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Lee HH

Subjects: Venous Thromboembolism*/Venous Thromboembolism*/Venous Thromboembolism*/diagnosis ; Venous Thromboembolism*/Venous Thromboembolism*/Venous Thromboembolism*/epidemiology ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/epidemiology

  • Source: Therapeutic advances in respiratory disease [Ther Adv Respir Dis] 2023 Jan-Dec; Vol. 17, pp. 17534666231155772.Publisher: SAGE Publications Country of Publication: England NLM ID: 101316317 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Adherence, Persistence, and Effectiveness in Real Life. Multicenter Long-Term Study on the Use of Pirfenidone and Nintedanib in the Treatment of Idiopathic Pulmonary Fibrosis.

Subjects: Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/diagnosis ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/drug therapy; Humans

  • Source: Journal of pharmacy practice [J Pharm Pract] 2022 Dec; Vol. 35 (6), pp. 853-858. Date of Electronic Publication: 2021 Apr 21.Publisher: Sage Publications Country of Publication: United States NLM ID: 8900945 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Idiopathic pulmonary fibrosis therapy development: a clinical pharmacology perspective.

  • Authors : Mai TH; Genentech Inc., South San Francisco, CA, USA.; Han LW

Subjects: Pharmacology, Clinical* ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/drug therapy; Humans

  • Source: Therapeutic advances in respiratory disease [Ther Adv Respir Dis] 2023 Jan-Dec; Vol. 17, pp. 17534666231181537.Publisher: SAGE Publications Country of Publication: England NLM ID: 101316317 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis.

  • Authors : Astor TL; Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.; Goldberg HJ

Subjects: Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/diagnosis ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/drug therapy ; Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/Idiopathic Pulmonary Fibrosis*/surgery

  • Source: Therapeutic advances in respiratory disease [Ther Adv Respir Dis] 2023 Jan-Dec; Vol. 17, pp. 17534666231165912.Publisher: SAGE Publications Country of Publication: England NLM ID: 101316317 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  147 results for ""Idiopathic Pulmonary Fibrosis""